|
Echocardiography
|
|
Tumor (n=31)
| | | | | |
|
1. Location outside the right atrium
|
72.7% (32/44)
|
71.0% (22/31)
|
76.9% (10/13)
|
88.0% (22/25)
|
52.6% (10/19)
|
|
2. Location outside the atria and ventricles
|
50.0% (22/44)
|
29.0% (9/31)
|
100% (13/13)
|
100% (9/9)
|
37.1%(13/35)
|
|
Malignant Tumor (n=17)
| | | | | |
|
1. Location outside the atria and ventricles
|
77.3% (34/44)
|
47.1% (8/17)
|
96.3% (26/27)
|
88.9% (8/9)
|
74.3% (26/35)
|
|
2. Non-Mobility
|
72.7% (32/44)
|
82.5% (14/17)
|
66.7% (18/27)
|
60.9% (14/23)
|
85.7% (18/21)
|
|
3. Pericardial effusion
|
75.0% (33/44)
|
52.9% (9/17)
|
88.9% (24/27)
|
75.0% (9/12)
|
75.0% (24/32)
|
|
CMR
|
|
Tumor (n=35)
| | | | | |
|
1. Location outside the right atrium
|
72.0% (36/50)
|
77.1% (27/35)
|
60.0% (9/15)
|
81.8% (27/33)
|
52.9% (9/17)
|
|
2. T2 Hyperintensity or Mixed Pattern
|
76.0% (38/50)
|
88.6% (31/35)
|
46.7% (7/15)
|
79.5% (31/39)
|
63.6% (7/11)
|
|
3. Contrast Enhancement on First Pass
|
86.0% (43/50)
|
82.9% (29/35)
|
93.3% (14/15)
|
96.7% (29/30)
|
70.0% (14/20)
|
|
4. Late Gadolinium Enhancement
|
86.0% (43/50)
|
85.7% (30/35)
|
86.7% (13/15)
|
93.8% (30/32)
|
72.2% (13/18)
|
|
Malignant Tumor (n=21)
| | | | | |
|
1. Location outside the atria and ventricles
|
76.0% (38/50)
|
61.9% (13/21)
|
86.2% (25/29)
|
76.5% (13/17)
|
75.8% (25/33)
|
|
2. Non-Mobility
|
78.0% (39/50)
|
95.2% (20/21)
|
65.5% (19/29)
|
66.7% (20/30)
|
95.0% (19/20)
|
|
3. Contrast Enhancement on First Pass
|
70.0% (35/50)
|
85.7% (18/21)
|
58.6% (17/29)
|
60.0% (18/30)
|
85.0% (17/20)
|
|
4. Late Gadolinium Enhancement
|
66.0% (33/50)
|
85.7% (18/21)
|
51.7% (15/29)
|
56.3% (18/32)
|
83.3% (15/18)
|
|
5. Myocardial Invasion
|
72.0% (36/50)
|
33.3% (7/21)
|
100% (29/29)
|
100% (7/7)
|
67.4% (29/43)
|
|
6. Pericardial Effusion
|
76.0% (38/50)
|
47.6% (10/21)
|
96.6% (28/29)
|
90.9% (10/11)
|
71.8% (28/39)
|
